Reata Pharmaceuticals Inc (RETA) stock is higher by 4.56% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With RETA Stock Today?
Reata Pharmaceuticals Inc (RETA) stock has gained 2.13% while the S&P 500 is lower by -0.33% as of 12:15 PM on Wednesday, Mar 3. RETA is up $2.75 from the previous closing price of $129.33 on volume of 131,738 shares. Over the past year the S&P 500 is higher by 24.82% while RETA is lower by -36.48%. RETA lost -$8.01 per share in the over the last 12 months.
To see the top 5 stocks in the Biotechnology industry click here.
More About Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.
Click Here to get the full Stock Score Report on Reata Pharmaceuticals Inc (RETA) Stock.
